Prophylactic Antimalarial Drugs - Infectious Diseases

Relevant Publications

Current Status of Malaria Control and Elimination in Africa: Epidemiology, Diagnosis, Treatment, Progress and Challenges.

Issue Release: 2024

Assessment of antimalarial activity of crude extract of Chan-Ta-Lee-La and Pra-Sa-Chan-Dang formulations and their plant ingredients for new drug candidates of malaria treatment: In vitro and in vivo experiments.

Issue Release: 2024

Nanotechnology based drug delivery systems for malaria.

Issue Release: 2024

Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs.

Issue Release: 2024

Targeted malaria elimination interventions reduce infections up to 3 kilometers away.

Issue Release: 2023

Glutaraldehyde modified red blood cells delivering artesunate to the liver as a dual therapeutic and prophylactic antimalaria strategy.

Issue Release: 2023

Creating and Validating Ligase Primers to Detect Single Nucleotide Polymorphisms Associated with Atovaquone Resistance in Plasmodium falciparum.

Issue Release: 2023

Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients.

Issue Release: 2023

In vivo assessment of the antimalarial activity and acute oral toxicity of an ethanolic seed extract of Spondias pinnata (L.f.) Kurz.

Issue Release: 2022

ANTIMALARIAL activities and alkaloids from Crinum jagus (Thomps) DANDY.

Issue Release: 2022

Suppressive, Curative, and Prophylactic Effects of Forssk. against Rodent Malaria Parasite .

Issue Release: 2022

RDT- AND MICROSCOPIC-BASED TRENDS OF MALARIA AMONG LOCAL AND MIGRANT POPULATIONS IN THE PROVINCE OF CENTRAL KALIMANTAN, INDONESIA DURING 2017-2020.

Issue Release: 2022

Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control.

Issue Release: 2022

Piperine Enhances the Antimalarial Activity of Curcumin in ANKA-Infected Mice: A Novel Approach for Malaria Prophylaxis.

Issue Release: 2022

Effect of α-Tocopheryloxy Acetic Acid on the Infection of Mice with Plasmodium berghei ANKA In Vivo and Humans with P. falciparum In Vitro.

Issue Release: 2022

Chloroquine-Induced Psychosis: A Case Report.

Issue Release: 2022

Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.

Issue Release: 2021

Antiplasmodial Activity of the Crude Extract and Solvent Fractions of Stem Barks of in -Infected Mice.

Issue Release: 2021

In-vivo anti-plasmodial activity of phosphate buffer extract of Calotropis procera latex in mice infected with Plasmodium berghei.

Issue Release: 2021

What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.

Issue Release: 2021

How are Stool Samples Collected?

What are Vaccinations?

Why is PCR Important in Infectious Diseases?

What are Antibiotics?

What Does a Regular Health Check-Up Entail?

What is the National Institutes of Health (NIH)?

What is Mycobacterium Tuberculosis?

How Do Immunodeficiency Disorders Affect the Body?

How Does the NIH Contribute to Infectious Disease Research?

What are the Treatment Options?

Prophylactic Antimalarial Drugs - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics